In this episode of The Good Bot, Brett Mason is joined by Rusty Close, Austin Padgett, and Brent Hoard to explore the complexities of contracting for artificial intelligence (AI) in health care. The conversation points to key intellectual property concerns, including ownership of AI-generated content and the impact of recent Copyright Office guidance.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We love to hear from our listeners. Send us a message. On episode 114 of Cell & Gene: The Podcast, Host Erin Harris talks to Brian Culley, CEO of Lineage Cell Therapeutics, about advancing cell therapy beyond oncology and into transformative treatments for conditions such as spinal cord injury and blindness. Culley shares how Lineage’s allogeneic, off-the-shelf approach, anchored by its OPC1 program, aims to replace lost or damaged cells to restore function, starting with patients who hav...

In this episode of Molecule to Market, you’ll hear wily old wisdom, golden nuggets and invaluable insider tips about CPHI. The nuanced stuff from Veterans of CPHIs gone by you’ll never find in a generic AI-written playbook. The show features:James West, Managing Director, Bourne Partners Arul Ramadurai, CCO at Axplora Christine Fuerst, Director Key Account Management Europe, Vetter Pharma International GmbH Dan Stanton, leading pharma/biopharma industry journalist Jeremy Drummond PhD, retired VP

This is a free preview of a paid episode. To hear more, visit www.razibkhan.comToday, Razib talks to Coltan Scrivner, a behavioral scientist, horror entertainment producer, and author, whose work centers on the psychological and evolutionary roots of our fascination with darkness, horror, and true crime. He is affiliated with the Department of Psychology at Arizona State University. Scrivner also serves as the executive director of the Nightmare in the Ozarks Film Festival and founded the Eureka

Dr. Don and Professor Ben talk about the risks from consuming opened organic lemonade refrigerated for 4 weeks. Dr. Don - not risky 👍🏼  Professor Ben - not risky 👍🏼   Kirkland Signature, Organic Lemonade, 96 fl oz, 2-Count | Costco mycotoxin fruit juice - Google Scholar Mycotoxins in Fruits, Fruit Juices, and Dried Fruits - ScienceDirect Ochratoxin A in beverages from Morocco: a preliminary survey: Food Additives and Contaminants: Vol 18 , No 6

Can you imagine parents expecting a baby, going in for an ultrasound, and finding out that their baby is missing the heart's left ventricle? This week on BioTech Nation, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, talks about how they are testing the use of stem cells to treat babies born with a serious congenital heart defect.

In this classic episode of Weirdhouse Cinema, Rob and Joe keep the terror train rolling down the tracks with a look at the 1972 sci-fi thriller "Horror Express," starring Christopher Lee, Peter Cushing, Alberto de Mendoza, Silvia Tortosa and Telly Savalas. (originally published 10/4/2024)See omnystudio.com/listener for privacy information.

AI is everywhere these days, and though there’s debate about how useful it is, one area where experts think it could be game-changing is scientific research. It promised to be particularly useful for speeding up drug discovery, an expensive and time-consuming process that can take decades. But so far, it hasn’t panned out.The few AI-designed drugs that have made it to clinical trials haven’t been approved, venture capital investment in these efforts has cratered in the last few years, and many

This episode is published by the Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).Thanks for listening and enjoy

This episode is published by the Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).Thanks for listening and enjoy

Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.

Mastering Recruiting: Why Building Genuine Relationships Will Always Matter #recruiting #executiverecruiting #talentacquisition In this interview with Janelle Razzino, we get deep into the core of successful recruiting, building genuine relationships. Please visit our website to get more information: https://swangroup.net/ While the landscape of recruiting has changed, the value of human connection remains paramount. Janelle shares her insights on why recruiting is all about peo...

Your process works perfectly at two-liter bench scale. Then you hit fifty liters and titer drops 20%. By two hundred liters, aggregation appears and charge variants shift. Your management team asks: "How long to fix this?" The honest answer? Three to twelve month, because you're flying blind. In Part 2 of this Quality by Design Master Class, David Brühlmann reveals why scale-up chaos isn't inevitable. It's a solvable engineering problem. Drawing on experience leading bioprocess innovation at ...

The rate of smoking cigarettes has steadily declined since the 1960s – when Congress required warnings on cigarette boxes. Research shows that people are more likely to try to quit smoking when they’re under 40. But a new study in the journal The Lancet Healthy Longevity shows that quitting later in life can still be beneficial – and could possibly lower your risk for dementia. For this and more news from the science journals, Short Wave hosts Regina G. Barber and Emily Kwong talk with All Things

Could your next meal be the key to preventing cancer?Colorectal cancer is one of the most common—but also one of the most preventable—types of cancer. And while it often develops quietly, early screening and smart dietary choices can dramatically reduce your risk. This week on Aging Less: The Longevity Science Insights Podcast, host Sabrina Oktavelia sits down with renowned medical oncologist and cancer researcher Prof. Ian Olver AM to explore the powerful role of prevention. Together, they unpack

In this episode, Roxie dives into the fascinating world of dreams — those strange, vivid, sometimes emotional stories that play out in our minds while we sleep. She explores both the science and the mystery behind dreaming, combining humor, research, and a few wonderfully weird personal anecdotes.Key Topics Covered:What dreams are and when they happen (REM vs. Non-REM sleep)Leading theories of why we dream:🧠 Memory consolidation💭 Emotional processing🎭 Activation-synthesis (random brain noise)⚔️

Given that most of us spend half our lives at work, it is no surprise that positive workplace interactions are critical for both our well-being and productivity. So, this week on Doing Well: The Wellbeing Science Insights Podcast, host Marie Stella interviews psychologist Ryan C. Warner for tips on how to foster positive interactions at work without coming off as disingenuous.A globally recognized speaker, award-winning psychologist, accomplished scholar, and military veteran, Dr. Ryan C. Warner

Misinformation can lead to costly mistakes, missed opportunities, or unnecessary fear. With the hype, confusion, and persistent myths surrounding cryptocurrency, it’s a great challenge to separate fact from fiction. So, this week on Wealth Pathways: The Affluence Science Insights Podcast, host Marie Stella is joined by postdoctoral researcher Maximilian Brichta to cut through the noise to reveal what smart investors need to know before jumping on the crypto bandwagon.Based out of the University of

In this episode, we take a closer look at the devastating impacts of federal funding cuts across the United States on developmental science and its trainees. We discuss how cuts are destabilizing training for early-career scientists and halting the vital research that they conduct. We further emphasize how scientists are organizing to fight back, and how we can take care of ourselves and each other along the way. For this crucial discussion, we are joined by Gabriel Leon, Shiba Esfand, a...

Today, we’re joined by Clarke Atwell, CEO of Claris Biotherapeutics — a company pioneering regenerative biologic therapies with a focus on transforming the field of ophthalmology.Under Clarke’s leadership, Claris has achieved a major milestone with its Series A financing, fueling the company’s mission to advance novel therapies designed to repair and restore vision at the cellular level, and are now in the process of going through there series B round. By combining cutting-edge biology with a deep